| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Vtv Therapeutics Inc. (VTVT) has 6 insiders with recent SEC Form 4 filings, including 10 buys and 0 sells. VTVT is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 2.40M | $74.51M | - | |
| Dir | 106.0K | $3.29M | - | |
| CFO | 45.0K | $1.40M | - | |
| Dir | 13.6K | $420.7K | - | |
| Dir | 10.9K | $337.1K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 29, 2019 | Perelman Ronald O | 10% Owner | Buy | 815,217 | $1.84 | $1,499,999.28 | +5.8% | |
| Jan 16, 2019 | Perelman Ronald O | 10% Owner | Buy | 815,217 | $1.84 | $1,499,999.28 | +6.2% | |
| Dec 27, 2018 | Perelman Ronald O | 10% Owner | Buy | 815,217 | $1.84 | $1,499,999.28 | +6.6% | |
| Nov 29, 2018 | Perelman Ronald O | 10% Owner | Buy | 1,879,700 | $1.33 | $2,500,001.00 | +17.8% | |
| Nov 6, 2018 | Perelman Ronald O | 10% Owner | Buy | 1,879,699 | $1.33 | $2,499,999.67 | +21.7% | |
| Sep 27, 2018 | Perelman Ronald O | 10% Owner | Buy | 1,879,699 | $1.33 | $2,499,999.67 | +27.7% | |
| Sep 6, 2018 | Savas Paul G | Director | Buy | 5,000 | $1.00 | $5,000.00 | +5.8% | |
| Sep 6, 2018 | Perelman Ronald O | 10% Owner | Buy | 1,879,699 | $1.33 | $2,499,999.67 | +38.4% | |
| Aug 10, 2018 | Perelman Ronald O | 10% Owner | Buy | 570,777 | $4.38 | $2,500,003.26 | +13.2% | |
| Jul 6, 2018 | Perelman Ronald O | 10% Owner | Buy | 570,776 | $4.38 | $2,499,998.88 | +15.2% |